APA

Sarli M., Novoa M. B., Mazzucco M. N., Signorini M. L., Echaide I. E., de Echaide S. T. & Primo M. E. (20200511). A vaccine using Anaplasma marginale subdominant type IV secretion system recombinant proteins was not protective against a virulent challenge. : PloS one.

Chicago

Sarli Macarena, Novoa María B, Mazzucco Matilde N, Signorini Marcelo L, Echaide Ignacio E, de Echaide Susana T and Primo María E. 20200511. A vaccine using Anaplasma marginale subdominant type IV secretion system recombinant proteins was not protective against a virulent challenge. : PloS one.

Harvard

Sarli M., Novoa M. B., Mazzucco M. N., Signorini M. L., Echaide I. E., de Echaide S. T. and Primo M. E. (20200511). A vaccine using Anaplasma marginale subdominant type IV secretion system recombinant proteins was not protective against a virulent challenge. : PloS one.

MLA

Sarli Macarena, Novoa María B, Mazzucco Matilde N, Signorini Marcelo L, Echaide Ignacio E, de Echaide Susana T and Primo María E. A vaccine using Anaplasma marginale subdominant type IV secretion system recombinant proteins was not protective against a virulent challenge. : PloS one. 20200511.